Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) Institutional Ownership

CUSIP: 185053402

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common Shares, no par value per share
Symbol
CMND on Nasdaq
Shares outstanding
2,174,400
Price per share
$0.07
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-281,131
Value change
-$288,305
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 185053402?
CUSIP 185053402 identifies CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Iroquois Capital Management, LLC 9.9% +62% $549,158 +$138,124 603,470 +34% Richard Abbe 30 Sep 2025
AdvisorShares Trust 4.8% $177,102 205,933 AdvisorShares Trust 30 Jun 2025
L.I.A. Pure Capital Ltd 5% -50% $7,610 -$411,017 108,720 -98% L.I.A. Pure Capital Ltd. 09 Feb 2026
Capitalink Ltd. 5% -50% $7,556 -$411,072 107,943 -98% Capitalink Ltd. 09 Feb 2026

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND). This represents 0% of the company’s total 2,174,400 outstanding shares.

Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$288,305 $0.07 0
2025 Q3 281,131 $288,305 +$41,508 $1.02 7
2025 Q2 244,330 $216,133 -$13,983 $0.88 7
2025 Q1 601,206 $5,451,442 -$30,388 $1.04 6
2024 Q4 612,804 $5,491,207 -$46,684 $1.38 9
2024 Q3 702,419 $5,494,319 +$5,284,113 $1.22 8
2024 Q2 165,796 $276,008 +$33,327 $1.68 4
2024 Q1 153,477 $175,314 +$69,644 $1.14 4
2023 Q4 92,693 $260,467 +$260,467 $2.81 1